TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent productdevelopment platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Charles P. Theuer, M.D.,PhD$4.1M
Market Cap • 25/04/20242004
(há 20 anos)
2015
(9 years ago)
NASDAQ
Listagem
San Diego
Sede • California18
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
TCONSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.